Correction to: NFATc2 is an intrinsic regulator of melanoma dedifferentiation.


Journal

Oncogene
ISSN: 1476-5594
Titre abrégé: Oncogene
Pays: England
ID NLM: 8711562

Informations de publication

Date de publication:
May 2019
Historique:
pubmed: 30 1 2019
medline: 30 1 2019
entrez: 30 1 2019
Statut: ppublish

Résumé

In Fig. 6e, the authors noticed that wrong blots for MITF, MART-1 expression/modulation, and for β-actin were presented, due to the similarity with experiments shown in Figure 5c. Correct MITF, MART-1, and β-actin blots were added to the revised Fig. 6 shown in the associated Correction. The meaning of the results shown in Fig.6e, as well as the conclusions of this paper were not affected, and the authors regret for this error. These errors have not been fixed in the original Article.

Identifiants

pubmed: 30692631
doi: 10.1038/s41388-019-0679-8
pii: 10.1038/s41388-019-0679-8
pmc: PMC8075923
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

3763-3764

Commentaires et corrections

Type : ErratumFor

Auteurs

V Perotti (V)

Human Tumors Immunobiology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

P Baldassari (P)

Human Tumors Immunobiology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

A Molla (A)

Human Tumors Immunobiology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

C Vegetti (C)

Human Tumors Immunobiology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

I Bersani (I)

Human Tumors Immunobiology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

A Maurichi (A)

Melanoma and Sarcoma Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

M Santinami (M)

Melanoma and Sarcoma Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

A Anichini (A)

Human Tumors Immunobiology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

R Mortarini (R)

Human Tumors Immunobiology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. roberta.mortarini@istitutotumori.mi.it.

Classifications MeSH